Expression of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions Nasser Chegini,

Slides:

Advertisements

Similar presentations

Date of download: 6/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Expression of Matrix Metalloproteinases and Their.

Advertisements

Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-β1 gene expression and protein.

Lipodermatosclerosis is Characterized by Elevated Expression and Activation of Matrix Metalloproteinases: Implications for Venous Ulcer Formation Yared.

Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of matrix metalloproteinase 9 (MMP-9) and tissue inhibitors.

Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling Baoping Cao, MD, PhD, Weili Yang,

Lucas R. Barbieri, MD, Domingos D. Lourenço-Filho, MD, PhD, Elaine R

Volume 42, Issue 4, Pages (October 2002)

Masanobu Ishii et al. BTS 2017;2:

MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint J. Xu, Y. Liu, M. Deng,

Volume 60, Issue 4, Pages (October 2001)

Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide Bin Li, M.S., Ming.

Fertility and Sterility

Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient Irina K. Dimitrova, M.D., Jennifer K. Richer,

Vein Graft Harvesting Induces Inflammation and Impairs Vessel Reactivity Kazuhiro Hinokiyama, MD, Guro Valen, MD, PhD, Shinichi Tokuno, MD, PhD, Jenny.

Eutopic endometrial interleukin-18 system mRNA and protein expression at the level of endometrial-myometrial interface in adenomyosis patients Hong-Yuan.

Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content Hazem Abdul-Hussien, MD, Roeland Hanemaaijer,

Presence of DAZL transcript and protein in mature human spermatozoa

Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism

Significance of mRNA levels of connexin37, connexin43, and connexin45 in luteinized granulosa cells of controlled hyperstimulated follicles Meng-Yin.

Keith A Hansen, M. D. , Leah Lowman, M. D. , Eric P Fiedler, M. D

Cytokine microenvironments in human first trimester decidua are dependent on trophoblast cells Ulrike von Rango, PhD, Irmgard Classen-Linke, PhD, Gabie.

Differential expression of elastin assembly genes in patients with Stanford Type A aortic dissection using microarray analysis Bernice L.Y. Cheuk, PhD,

Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts Ghassan M Saed,

Modulation of the BCL-2/BAX ratio by interferon-γ and hypoxia in human peritoneal and adhesion fibroblasts Ghassan M. Saed, Ph.D., Zhongliang Jiang,

Julie L. V. Shaw, Ph. D. , Fiona C. Denison, M. B. , Ch. B. , M. D

Human uterine and ovarian expression of growth hormone–releasing hormone messenger RNA in benign and malignant gynecologic conditions Omid Khorram, M.D.,

Regine Gaetje, M. D. , Uwe Holtrich, Ph. D. , Thomas Karn, Ph. D

Endometrial stromal progesterone receptor-A/progesterone receptor-B ratio: no difference between women with and without endometriosis Davide Gentilini,

Panagiotis Bakas, M. D. , Angelos Liapis, M. D

Interleukin-18 system messenger RNA and protein expression in human endometrium during the menstrual cycle Hong-Yuan Huang, M.D., She-Hung Chan, B.Sc.,

Fertility and Sterility

Critical Evaluation of Real-Time Reverse Transcriptase-Polymerase Chain Reaction for the Quantitative Detection of Cytokeratin 20 mRNA in Colorectal Cancer.

Intense pulsed light irradiation may reverse activator protein-1 expression induced by ultraviolet B light Gwo-Shing Chen, MD, PhD, Hui-Chuan Lin, MS,

Increased frequency of human leukocyte antigen–E inhibitory receptor CD94/NKG2A– expressing peritoneal natural killer cells in patients with endometriosis

Pathophysiologic features of “thin” endometrium

Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development Mark Payson, M.D., Minnie Malik,

Adenovirus-mediated expression of cyclooxygenase-2 antisense reverse abnormal genetic profile of human adhesion fibroblasts Ghassan M. Saed, Ph.D., Ayman.

Rahi Victory, M. D. , F. R. C. S. C. , Ghassan M. Saed, Ph. D

Eszter Ducza, Ph. D. , Róbert Gáspár, Ph. D. , Attila Mihályi, Ph. D

Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytes J.N.A. De Croos, Ph.D., B. Jang,

Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency Satoshi Saito, MD, Matthew.

Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-β1 gene expression and protein.

Expression of transforming growth factor (TGF)-β1, TGF-β2, and TGF-β3 and of type I and II TGF-β receptors during the development of the human fetal ovary

Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: a comparison of pregnant and obese women Suman Rice, Ph.D., Bijal Patel,

Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-

Philip Kressin, M. D. , Eva-Maria Wolber, Ph. D. , Harald Wodrich, Ph

Characterization of messenger RNA expression of estrogen receptor-α and -β in patients with ovarian endometriosis Sachiko Matsuzaki, M.D., Takao Fukaya,

Interleukin-1 system messenger ribonucleic acid and protein expression in human fallopian tube may be associated with ectopic pregnancy Hong-Yuan Huang,

Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture Michael P. Grossman, M.D., Steven T.

Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells Jian Liu, MD, Wanfen Xiong, PhD,

Peritoneal fluid concentrations of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta in women with.

Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis- associated infertility Barbara H Osborn, M.D., A.F Haney, M.D.,

Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase Xiaoxi Sun, M.D., Xiaoyan.

Sinus mucosal IL-8 gene expression in chronic rhinosinusitis

Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor Jason D. Parker, D.O., Minnie.

Local injury of the endometrium induces an inflammatory response that promotes successful implantation Yulia Gnainsky, Ph.D., Irit Granot, Ph.D., Paulomi.

Lin Mu, Ph. D. , Wei Zheng, Ph. D. , M. D. , Liang Wang, Ph. D

Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion.

Expression of transforming growth factor beta isoform mRNA in injured peritoneum that healed with adhesions and without adhesions and in uninjured peritoneum

Identification of differential gene expression in germinal vesicle vs

Wanfen Xiong, MD, PhD, Rebecca Knispel, BS, Jason Mactaggart, MD, B

Expression of the platelet-activating factor receptor in human spermatozoa: differences in messenger ribonucleic acid content and protein distribution.

Se-Jin Yoon, Ph. D. , Deog-Bon Koo, Ph. D. , Jung Sun Park, M. Sc

Fig. 1. Wnt5a expression in psoriasis

Fig. 2. Notch1 and hairy and enhancer of split (HES) 1 expression in psoriasis. (A) Quantitative reverse transcription polymerase chain reaction results.

Altered circulating levels of matrix metalloproteinases 2 and 9 and their inhibitors and effect of progesterone supplementation in women with endometriosis.

Ghassan M Saed, Ph.D., Michael P Diamond, M.D. Fertility and Sterility

Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization Luca Sabatini,

Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions Nasser Chegini,

Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human preimplantation embryos Hongbo Wang, M.D., Yan Wen, M.D.,

Presentation transcript:

Expression of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions Nasser Chegini, Ph.D., Kristina Kotseos, B.Sc., Yong Zhao, M.D., Chunfeng Ma, M.D., Ph.D., Frederick McLean, M.D., Michael P. Diamond, M.D., Lena Holmdahl, M.D., Ph.D., James Burns, Ph.D. Fertility and Sterility Volume 76, Issue 6, Pages 1212-1219 (December 2001) DOI: 10.1016/S0015-0282(01)02875-8

FIGURE 1 Competitive quantitative reverse transcriptase polymerase chain reaction (PCR) analysis of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP-1 (TIMP-1) messenger RNA using total cellular RNA isolated from parietal peritoneum. The upper bands are the PCR products generated from the specific message in cellular RNA, and the lower bands are from the standard complementary RNA (shown from right to left at dilutions corresponding to 108 to 103 and 107 to 102 copies/reaction). M = DNA markers. Chegini. MMP-1 and TIMP-1 in serosal tissue. Fertil Steril 2001. Fertility and Sterility 2001 76, 1212-1219DOI: (10.1016/S0015-0282(01)02875-8)

FIGURE 2 Expression of matrix metalloproteinase (A) and tissue inhibitor of MMP-1 (B) messenger RNA (mRNA) expression in serosal tissue of parietal peritoneum, various peritoneal organs, adhesions, and skin. Values were calculated from the band densities described in Materials and Methods. Results are means ± SE of copies of mRNA/μg total RNA. In panel A, P<.05 for b compared with a, c, and d; P=.01 for b compared with g, h, j, and k; and P<.01 for a, b, c, d, e, and f compared with g, h, j, and k. In panel B, P<.05 for d compared with a, b, c, f, g, j, and k. Chegini. MMP-1 and TIMP-1 in serosal tissue. Fertil Steril 2001. Fertility and Sterility 2001 76, 1212-1219DOI: (10.1016/S0015-0282(01)02875-8)

FIGURE 3 Notched box plots showing the level of matrix metalloproteinase (MMP-1) (A) and tissue inhibitor of MMP-1 (TIMP-1) (B) in samples of serosal tissue of the ovaries, uterus, fallopian tubes (F. tube), large bowel, omentum, skin, fascia, and adhesions. The vertical line within the box boundaries represent the distribution of the middle 50%, the thin horizontal lines within the boxes are the medians, and the thick lines are the arithmetric means. The notches represent the 95th percentile, and the error bars represent the 90th and 10th percentiles. Levels of MMP-1 levels in skin, fascia, peritoneum and omentum were significantly lower than those in uterus, ovary, fallopian tube, and large bowel (P=.005, .003, and .01, respectively), and TIMP-1 levels in skin and fascia were significantly lower than those in uterus, ovary, fallopian tube, and large bowel (P=.002, .05 and .0004, respectively). Chegini. MMP-1 and TIMP-1 in serosal tissue. Fertil Steril 2001. Fertility and Sterility 2001 76, 1212-1219DOI: (10.1016/S0015-0282(01)02875-8)

FIGURE 4 Mean ± SE matrix metalloproteinase (MMP-1) (A) and tissue inhibitor of MMP-1 (TIMP-1) (B) protein content in adhesions, intact parietal peritoneum, and skin of 10 patients with adhesions. The TIMP-1 protein content in adhesions is significantly higher than that in intact parietal peritoneum (P=.05) and skin (P=.03). Chegini. MMP-1 and TIMP-1 in serosal tissue. Fertil Steril 2001. Fertility and Sterility 2001 76, 1212-1219DOI: (10.1016/S0015-0282(01)02875-8)

FIGURE 5 (A), Ratio of matrix metalloproteinase (MMP-1) to tissue inhibitor of MMP-1 (TIMP-1) in serosal tissue of the parietal peritoneum, uterus, ovaries, fallopian tubes (F. tube), large bowels, skin, fascia, omentum, and adhesions. The ratio of MMP-1 to TIMP-1 in skin, fascia, and peritoneum is significantly lower than in other tissues (P<.001) and is lower in adhesions than in uterus and ovary (P=.03 and .001, respectively). (B), Percentiles of MMP-1 associated with TIMP-1 in the tissue extracts, calculated by using the equation indicated on the Y axis. (C), Ratio of MMP-1 to TIMP-1 in adhesions, parietal peritoneum, and skin from 10 patients with adhesions. The ratio of these substances in adhesions is significantly lower than that in peritoneum and skin (P<.05 for ∗ compared with ∗∗). Chegini. MMP-1 and TIMP-1 in serosal tissue. Fertil Steril 2001. Fertility and Sterility 2001 76, 1212-1219DOI: (10.1016/S0015-0282(01)02875-8)